DK154283A - Produkter og metoder til behandling af cancer - Google Patents

Produkter og metoder til behandling af cancer Download PDF

Info

Publication number
DK154283A
DK154283A DK154283A DK154283A DK154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A DK 154283 A DK154283 A DK 154283A
Authority
DK
Denmark
Prior art keywords
methods
cancer treatment
treatment products
products
cancer
Prior art date
Application number
DK154283A
Other languages
English (en)
Other versions
DK154283D0 (da
Inventor
David Stephen Terman
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of DK154283D0 publication Critical patent/DK154283D0/da
Publication of DK154283A publication Critical patent/DK154283A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK154283A 1982-04-07 1983-04-07 Produkter og metoder til behandling af cancer DK154283A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
DK154283D0 DK154283D0 (da) 1983-04-07
DK154283A true DK154283A (da) 1983-10-08

Family

ID=27003359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK154283A DK154283A (da) 1982-04-07 1983-04-07 Produkter og metoder til behandling af cancer

Country Status (13)

Country Link
EP (1) EP0091784B1 (da)
AU (2) AU569467B2 (da)
CA (1) CA1230555A (da)
DE (1) DE3374756D1 (da)
DK (1) DK154283A (da)
ES (5) ES521279A0 (da)
FI (1) FI831169L (da)
GB (2) GB2119803B (da)
GR (1) GR78514B (da)
NO (5) NO831223L (da)
PT (1) PT76505B (da)
RO (3) RO89498A (da)
ZW (1) ZW7583A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
WO1994024275A1 (en) * 1993-04-08 1994-10-27 Board Of Regents, The University Of Texas System Model for gonococcal infection
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
WO2010132847A1 (en) * 2009-05-14 2010-11-18 Oatmeal Biotechnologies Group, L.L.C. Platform technologies for spontaneously occurring diseases
ES2900302T3 (es) * 2016-04-28 2022-03-16 Alkahest Inc Fracciones de plasma como terapia para el crecimiento y la progresión del tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
SE7904276L (sv) * 1978-05-17 1979-11-18 Benzon As Alfred Renat cancerassocierat protein

Also Published As

Publication number Publication date
GB2163164B (en) 1986-09-03
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
GB8309348D0 (en) 1983-05-11
ZW7583A1 (en) 1983-06-29
AU1286583A (en) 1983-10-13
RO89496A (ro) 1986-06-30
ES528120A0 (es) 1985-04-16
RO89498A (ro) 1986-06-30
FI831169L (fi) 1983-10-08
AU1560088A (en) 1988-10-27
DE3374756D1 (en) 1988-01-14
NO831223L (no) 1983-10-10
NO841495L (no) 1983-10-10
EP0091784B1 (en) 1987-12-02
EP0091784A2 (en) 1983-10-19
ES8503953A1 (es) 1985-04-16
EP0091784A3 (en) 1984-07-11
GB2163164A (en) 1986-02-19
GB8510892D0 (en) 1985-06-05
ES528121A0 (es) 1985-11-01
PT76505A (en) 1983-05-01
NO841498L (no) 1983-10-10
ES8503950A1 (es) 1985-04-16
NO841497L (no) 1983-10-10
DK154283D0 (da) 1983-04-07
AU569467B2 (en) 1988-02-04
ES528119A0 (es) 1985-04-16
FI831169A0 (fi) 1983-04-06
GR78514B (da) 1984-09-27
ES8405621A1 (es) 1984-06-16
CA1230555A (en) 1987-12-22
NO841496L (no) 1983-10-10
RO86661B (ro) 1985-03-01
ES8503954A1 (es) 1985-04-16
ES528118A0 (es) 1985-04-16
ES521279A0 (es) 1984-06-16
GB2119803A (en) 1983-11-23
PT76505B (en) 1986-05-05
RO86661A (ro) 1986-07-30

Similar Documents

Publication Publication Date Title
DK516883D0 (da) Fremgangsmade og anlaeg til diffraktionstomografi
DK343882A (da) Ostomiudstyr og fastgoerelsesplade hertil
DK159984C (da) Proces- eller behandlingsapparat
DK401583D0 (da) Parenkymal celle-cellulose og beslaegtede materialer
DK276683D0 (da) Carbapenemer og fremgangsmade til fremstilling deraf
DK462583A (da) Insekticidt produkt og fremgangsmaade til fremstilling deraf
DK150361C (da) Afgroedebehandlingsapparat
NO167615C (no) Fremgangsmaate og innretning for filtrering av elektromagnetisk straaling.
DK590383D0 (da) Pyrimidonderivater og fremgangsmade til fremstilling heraf
DK483083D0 (da) Platin-diamin komplekser og fremgangsmade til fremstilling deraf
DK567781A (da) Phenoxyalkoxysilaner og fremgangsmaade til fremstilling heraf
NO822219L (no) Fremgangsmaate og anordning for komprimering av elementer av tre
DK537481A (da) 5-amino-1-phenyl-4-cyanpyrazoler og fremgangsmaade til fremstilling heraf
DK137582A (da) Praeparater i pulverform indeholdende pesticider og egnede til bahandling af bohave
DK352683D0 (da) Plastforet roersamling og fremgangsmade til samling
DK154283A (da) Produkter og metoder til behandling af cancer
DK404783A (da) Octahydrobenz(f)isoquinoliner og fremgangsmaade til fremstilling heraf
DK297583A (da) Tricycliske forbindelser og fremgangsmaade til fremstilling heraf
DK481481A (da) Opsamlings og indkasseringsapparat til moenter
DK271281A (da) Haardfeldt og fremgangsmaade til fremstilling deraf
NO870125D0 (no) Fremgangsmaate og anordning for roerutlegning.
DK565783A (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin
NO823424L (no) Fremgangsmaate til fremstilling og behandling av ferrokrom
IT1189033B (it) Apparecchio ortopedico e procedimento di applicazione
DK606383D0 (da) Foderstof til droevtyggere og fremgangsmade til fremstilling af samme

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired